LY83583 (Standard)
LY83583 (Standard) is the analytical standard of LY83583. This product is intended for research and analytical applications. LY83583 is inhibitor of soluble guanylate cyclase (sGC) with the ability to target the cGMP signaling pathway. LY83583 inhibits the kinase activity-related proliferation of tumor cells by inducing the Cdk inhibitor p21. LY83583 can be used for the study of cancers (colorectal cancer, breast cancer and melanoma) and cardiovascular disease[1][2][3].
Product Specifications
CAS Number
91300-60-6
UNSPSC
12352005
Target
Guanylate Cyclase; Reference Standards
Related Pathways
GPCR/G Protein; Others
Field of Research
Cancer; Neurological Disease; Cardiovascular Disease
Smiles
O=C1C=C(NC2=CC=CC=C2)C(C3=C1N=CC=C3)=O
Molecular Formula
C15H10N2O2
Molecular Weight
250.26
References & Citations
[1]Lodygin D, et al. Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. J Clin Invest. 2002 Dec;110 (11) :1717-27. |[2]Kontos HA, et al. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke. 1993 Mar;24 (3) :427-34.|[3]Prasad RK, et al. LY-83583 stimulates glucose transporter-1-mediated glucose transport independent of changes in cGMP levels. Eur J Pharmacol. 1999 Jan 29;366 (1) :101-9.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
N004-405S-500UL 1x 500 µL
Alpaca Anti-Mouse IgG1 (Fc), rVHH (N2504.M1FC), CF®405S, MiniMabTM
Sign In for Pricing
View Details 
ARP69409_P050-HRP 100 µL
C8orf42 Antibody - N-terminal region : HRP (ARP69409_P050-HRP)
Sign In for Pricing
View Details